ProteoGenix engages in the development and commercialization of diagnostic testing products for the maternal-fetal health community. Its products include non-invasive diagnostics tests to detect intraamniotic infection, neonatal sepsis, preterm birth, preeclampsia, and down syndrome. ProteoGenix, Inc. was founded in 2002 and is based in Costa Mesa,